Articles

Podcasts

Videos

GASTROINTESTINAL INFECTIONS

RHB-105 (Talicia) is the only rifabutin-based therapy approved for the treatment of H pylori infection and is designed to address the high resistance of H pylori bacteria to current clarithromycin-based standard-of-care therapies. 

FDA Approves RHB-105 to Treat H Pylori

Helicobacter pylori resistance to clarithromycin more than doubled during the past 20 years, according to new research presented at UEG Week Barcelona 2019.

Antibiotic-Resistant H Pylori is on the Rise in Europe

In a recent study, researchers from several institutions found that individuals from North, Central, and South Americas may be at an increased risk of cancer due to Heliobacter pylori strains brought over to the "New World" with European explorers.

Gut Bacteria "Mismatch" Could Increase Gastric Cancer Risk

News on Heliobacter pylori, Zika, Clostridium difficile, Powassan virus, and influenza make up the top 5 news articles from Contagion® in March 2017.

Top 5 Contagion® News Articles for the Month of March 2017

In a new study, researchers have discovered that Helicobacter pylori, the presence of which is a risk factor for stomach cancer, uses multiple acid sensors to control colonization of the stomach.

H. PYLORI